OptiNose Inc. Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -16.32. In total, the insiders bought 7 340 117 and sold 11 339 392 OPTN shares in the last 100 trades.

Insider Power

(Last 100 transactions)
-16.32
Buy 7 340 117 Shares
Sell 11 339 392 Shares

Historical Insider Trades

Date Type Action Person Amount
Jun 18, 2024 Common Stock Sell Krick Anthony J 624
Jun 18, 2024 Common Stock Sell Marino Michael F Iii 2 946
Jun 18, 2024 Common Stock Sell Marino Michael F Iii 3 267
Jun 18, 2024 Common Stock Sell Mahmoud Ramy A 18 987
Jun 15, 2024 Common Stock Buy Marino Michael F Iii 3 817
Jun 15, 2024 Common Stock Buy Mahmoud Ramy A 6 113
Jun 06, 2024 Stock Option (Right to Buy) Buy Fletcher R John 85 000
Jun 06, 2024 Stock Option (Right to Buy) Buy Helton Sandra L 75 000
Jun 06, 2024 Stock Option (Right to Buy) Buy Groenhuysen Wilhelmus Cm 75 000
Jun 06, 2024 Stock Option (Right to Buy) Buy Dempsey Kyle 75 000
Jun 06, 2024 Stock Option (Right to Buy) Buy Heyman Tomas J. 75 000
Jun 06, 2024 Stock Option (Right to Buy) Buy Bednarski Eric 75 000
Jun 06, 2024 Stock Option (Right to Buy) Buy Owen Catherine E. 75 000
Mar 18, 2024 Common Stock Sell Krick Anthony J 2 345
Mar 18, 2024 Common Stock Sell Marino Michael F Iii 15 059
Mar 18, 2024 Common Stock Sell Mahmoud Ramy A 19 198
Mar 15, 2024 Common Stock Buy Marino Michael F Iii 3 816
Mar 15, 2024 Common Stock Buy Mahmoud Ramy A 6 114
Feb 28, 2024 Common Stock Buy Krick Anthony J 112 500
Feb 28, 2024 Stock Option (Right to Buy) Buy Krick Anthony J 56 250
Feb 28, 2024 Common Stock Buy Spence Paul Jr. 252 675
Feb 28, 2024 Stock Option (Right to Buy) Buy Spence Paul Jr. 126 338
Feb 28, 2024 Common Stock Buy Marino Michael F Iii 280 000
Feb 28, 2024 Stock Option (Right to Buy) Buy Marino Michael F Iii 140 000
Feb 28, 2024 Common Stock Buy Mahmoud Ramy A 795 975
Click to get the best stock tips daily for free!

About OptiNose Inc.

OptiNose. OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps, as well as is in Phase IIIb c... OPTN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT